Risperidone: Metabolic changes, as seen by dose-dependent elevations of cholesterol, triglyceride, LDL and VLDL concentrations within 6 weeks of risperidone therapy, are other atypical features seen in our patient. The combination of increasing weight along with abdominal adiposity and dyslipidaemic changes may herald the onset of metabolic syndrome.
Answered 7/27/2014
3.8k views
2 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question